No Data
Non-Opioid Pain Therapy-Focused Semnur Pharmaceuticals Strikes $2B SPAC Deal For NASDAQ Debut
Semnur Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company (NASDAQ:SCLX), and Denali Capital Acquisition Corp. (NASDAQ:DECA), a special purpose acquisition company, signed a lett
Sector Update: Health Care Stocks Steady Pre-Bell Wednesday
Health care stocks were steady pre-bell Wednesday as the Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) were inactive recently. CureVac (CVAC) and GSK (GSK) said they re
Express News | Scilex Holding Pares Gain in Premarket, Last up 7.7%
Scilex Shares Are Trading Higher After the Company's Semnur Pharmaceuticals Subsidiary Signed a Letter of Intent for a Proposed Business Combination With Denali Capital Acquisition Corp.
Scilex Shares Are Trading Higher After the Company's Semnur Pharmaceuticals Subsidiary Signed a Letter of Intent for a Proposed Business Combination With Denali Capital Acquisition Corp.
Express News | Scilex Holding Shares Jump 33.1% Premarket After Co-Backed Semnur Pharmaceuticals to Go Public in a $2 Billion SPAC Deal With Denali Capital
Scilex Holding Explores Strategic Options for Semnur Pharmaceuticals